Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation

Yıl: 2022 Cilt: 27 Sayı: 1 Sayfa Aralığı: 16 - 21 Metin Dili: İngilizce DOI: 10.5505/ejm.2022.91328 İndeks Tarihi: 11-10-2022

Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation

Öz:
Two-sided atherosclerotic involvement of peripheral arteries is common in clinical practice; however, the data about it in the literature is limited. This study aimed to investigate the frequency, clinical characteristics, and predictors of bilateral symmetric total superficial femoral artery (SFA) occlusions (mirror lesions). Between January 2015 and April 2020, 167 patients with symptomatic total SFA occlusions were retrospectively analyzed. Unilateral and bilateral SFA occlusions were determined, and the risk factors and clinical presentation were investigated between the two groups. Among 167 patients, 95 (57%) had bilateral SFA lesions, and 30 (18%) presented with critical limb ischemia (CLI). In the bilateral SFA occlusion group, male sex was dominant (p=0.002), and peripheral artery disease (PAD) history was higher (p=0.030). Additional iliac lesions (p = 0.003) and below-knee lesions (p <0.001) were more common in the bilateral SFA occlusion group. The sensitivity of Doppler ultrasonography in detecting SFA occlusions was 83.9%. In multivariate logistic regression analysis, younger age (OR; 0.95 CI; 0.91-0.99 p = 0.030) and history of PAD (OR; 2.08 CI; 1.02- 4, 24 p = 0.040) were identified as independent markers for predicting mirror SFA occlusions Our study demonstrates that the mirror lesion pattern is common in patients with symptomatic SFA total occlusion. Thus, the non-index leg evaluation should be recommended. The younger the age, and PAD history were the predictors of mirror total SFA occlusions.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006; 13: II30-40.
  • 2. Neupane S, Edla S, Maidona E et al. Long-term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease. Catheter Cardiovasc Interv 2018; 92: 117-123.
  • 3. Yahagi K, Otsuka F, Sakakura K et al.Pathophysiology of superficial femoral artery in-stent restenosis. J Cardiovasc Surg (Torino) 2014; 55: 307-23.
  • 4. Sampson UK, Fowkes FG, McDermott MM et al. Global and regional burden of death and disability from peripheral artery disease. Glob Heart 2014; 9: 145-158.e21.
  • 5. Yiğit G, Sarıcıoğlu MC, Çetinkaya F. Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. Turkish Journal of Vascular Surgery 2020;29(1):7-12
  • 6. Firnhaber JM, Powell CS. Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment. Am Fam Physician 2019; 99: 362-369.
  • 7. Kiesz RS, Góra B, Kolarczyk-Haczyk A et al. Clinical significance of mirror lesions in lower extremity arterial disease. Catheter Cardiovasc Interv 2020; 95: 300-306.
  • 8. Vink A, Schoneveld AH, Richard W et al. Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors? J Am Coll Cardiol 2001; 38: 718-723.
  • 9. Rutherford RB, Baker JD, Ernst C et al. Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 1997; 26: 517-538.
  • 10. Shrikhande GV, Graham AR, Aparajita R et al. Determining criteria for predicting stenosis with ultrasound duplex after endovascular intervention in infrainguinal lesions. Ann Vasc Surg 2011; 25: 454-460.
  • 11. Criqui M, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015; 116: 1509-1526.
  • 12. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007; 49: 2379-2393.
  • 13. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17: 648-655.
  • 14. Clarà A, Merino J, Planas A et al. Infrapopliteal arterial occlusive disease in elderly men: a population-based study. Int Angiol 2012; 31: 245-251.
  • 15. Gerhard-Herman MD, Gornik HL, Barrett C et al. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med 2017; 22: NP1-NP43.
  • 16. Collins R, Cranny G, Burch J et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007; 11: iii-iv, xi-xiii, 1-184
  • 17. Çakmak EÖ, Bayam E, Yilmaz F et al. Midterm Outcomes on Primary Endovascular Treatment of 395 Aortoiliac Occlusive Disease Patients: A Single-Center Experience. Angiology 2021; 72: 640-650.
  • 18. Valentine RJ, Jackson MR, Modrall JG, McIntyre KE, Clagett GP. The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service. J Vasc Surg 1999; 30: 436-445.
  • 19. Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg 2003; 37: 1219-1225.
  • 20. Aboyans V, Ricco JB, Bartelink MEL et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39: 763-816.
APA Erdogan E, Cakmak E, İmanov E, Tosun A, Tekatlı A, Geçmen Ç, Külahcioglu S, zehir r, Sismanoglu M, koksal c (2022). Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. , 16 - 21. 10.5505/ejm.2022.91328
Chicago Erdogan Emrah,Cakmak Ender Ozgun,İmanov Elmin,Tosun Ayhan,Tekatlı Ali Furkan,Geçmen Çetin,Külahcioglu Seyhmus,zehir regayip,Sismanoglu Mesut,koksal cengiz Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. (2022): 16 - 21. 10.5505/ejm.2022.91328
MLA Erdogan Emrah,Cakmak Ender Ozgun,İmanov Elmin,Tosun Ayhan,Tekatlı Ali Furkan,Geçmen Çetin,Külahcioglu Seyhmus,zehir regayip,Sismanoglu Mesut,koksal cengiz Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. , 2022, ss.16 - 21. 10.5505/ejm.2022.91328
AMA Erdogan E,Cakmak E,İmanov E,Tosun A,Tekatlı A,Geçmen Ç,Külahcioglu S,zehir r,Sismanoglu M,koksal c Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. . 2022; 16 - 21. 10.5505/ejm.2022.91328
Vancouver Erdogan E,Cakmak E,İmanov E,Tosun A,Tekatlı A,Geçmen Ç,Külahcioglu S,zehir r,Sismanoglu M,koksal c Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. . 2022; 16 - 21. 10.5505/ejm.2022.91328
IEEE Erdogan E,Cakmak E,İmanov E,Tosun A,Tekatlı A,Geçmen Ç,Külahcioglu S,zehir r,Sismanoglu M,koksal c "Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation." , ss.16 - 21, 2022. 10.5505/ejm.2022.91328
ISNAD Erdogan, Emrah vd. "Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation". (2022), 16-21. https://doi.org/10.5505/ejm.2022.91328
APA Erdogan E, Cakmak E, İmanov E, Tosun A, Tekatlı A, Geçmen Ç, Külahcioglu S, zehir r, Sismanoglu M, koksal c (2022). Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. Eastern Journal of Medicine, 27(1), 16 - 21. 10.5505/ejm.2022.91328
Chicago Erdogan Emrah,Cakmak Ender Ozgun,İmanov Elmin,Tosun Ayhan,Tekatlı Ali Furkan,Geçmen Çetin,Külahcioglu Seyhmus,zehir regayip,Sismanoglu Mesut,koksal cengiz Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. Eastern Journal of Medicine 27, no.1 (2022): 16 - 21. 10.5505/ejm.2022.91328
MLA Erdogan Emrah,Cakmak Ender Ozgun,İmanov Elmin,Tosun Ayhan,Tekatlı Ali Furkan,Geçmen Çetin,Külahcioglu Seyhmus,zehir regayip,Sismanoglu Mesut,koksal cengiz Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. Eastern Journal of Medicine, vol.27, no.1, 2022, ss.16 - 21. 10.5505/ejm.2022.91328
AMA Erdogan E,Cakmak E,İmanov E,Tosun A,Tekatlı A,Geçmen Ç,Külahcioglu S,zehir r,Sismanoglu M,koksal c Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. Eastern Journal of Medicine. 2022; 27(1): 16 - 21. 10.5505/ejm.2022.91328
Vancouver Erdogan E,Cakmak E,İmanov E,Tosun A,Tekatlı A,Geçmen Ç,Külahcioglu S,zehir r,Sismanoglu M,koksal c Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation. Eastern Journal of Medicine. 2022; 27(1): 16 - 21. 10.5505/ejm.2022.91328
IEEE Erdogan E,Cakmak E,İmanov E,Tosun A,Tekatlı A,Geçmen Ç,Külahcioglu S,zehir r,Sismanoglu M,koksal c "Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation." Eastern Journal of Medicine, 27, ss.16 - 21, 2022. 10.5505/ejm.2022.91328
ISNAD Erdogan, Emrah vd. "Superficial Femoral Artery Mirror Lesions; Risk Factors, Diagnosis, and Clinical Presentation". Eastern Journal of Medicine 27/1 (2022), 16-21. https://doi.org/10.5505/ejm.2022.91328